JAK 1/2突变:CAR-T 细胞治疗复发的一种潜在机制?
序号 | 标题 | 类型 | 作者 |
---|---|---|---|
1 | A phase I study of anti-BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia | 期刊论文 | Li Chunrui;Cao Wenyue;Que Yimei;Wang Qiuxiang;Xiao Yi;Gu Chaojiang;Wang Di;Wang Jue;Jiang Lijun;Xu Hao;Xu Jinhuan;Zhou Xiaoxi;Hong Zhenya;Wang Na;Huang Liang;Zhang Shangkun;Chen Liting;Mao Xia;Xiao Min;Zhang Wei;Meng Li;Cao Yang;Zhang Tongcun;Li Jian;Z |
2 | A Phase I Study of a Novel Fully Human BCMA-Targeting CAR (CT103A) in Patients with Relapsed/Refractory Multiple Myeloma | 期刊论文 | Wang D;Wang J;Hu G;Wang W;Xiao Y;Cai H;Jiang L;Meng L;Yang Y;Zhou X;Hong Z;Yao Z;Xiao M;Chen L;Mao X;Zhu L;Wang J;Qiu L;Li C;Zhou J |
3 | Anti-BCMA CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma Patients With Extramedullary Disease: A Single Center Analysis of Two Clinical Trials | 期刊论文 | Que Yimei;Xu Menglei;Xu Yanjie;Almeida Varlene Daniela Fernandes;Zhu Li;Wang Zhiqiong;Wang Ying;Liu Xian;Jiang Lijun;Wang Di;Li Chunrui;Zhou Jianfeng |
4 | Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies | 期刊论文 | Wang Na;Hu Xuelian;Cao Wenyue;Li Chunrui;Xiao Yi;Cao Yang;Gu Chaojiang;Zhang Shangkun;Chen Liting;Cheng Jiali;Wang Gaoxiang;Zhou Xiaoxi;Zheng Miao;Mao Xia;Jiang Lijun;Wang Di;Wang Qiuxiang;Lou Yaoyao;Cai Haodong;Yan Dandan;Zhang Yicheng;Zhang Tongcun;Zhou Jianfeng;Huang Liang |